Telix Pharmaceuticals Limited (TLX.AX)
AUD 29.27
(-0.17%)
AUD 29.27
(-0.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 308.5 Million AUD | 951.58% |
| 2022 | 29.33 Million AUD | 198.56% |
| 2021 | -29.76 Million AUD | -76.36% |
| 2020 | -16.87 Million AUD | -42.12% |
| 2019 | -11.87 Million AUD | -6185.31% |
| 2018 | 195.14 Thousand AUD | 5244.79% |
| 2017 | -3793.00 AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 123.88 Million AUD | 0.0% |
| 2023 Q2 | 90.81 Million AUD | 0.0% |
| 2023 FY | 308.5 Million AUD | 951.58% |
| 2023 Q4 | 223.97 Million AUD | 0.0% |
| 2022 Q4 | 44.89 Million AUD | 0.0% |
| 2022 FY | 29.33 Million AUD | 198.56% |
| 2022 Q2 | -15.57 Million AUD | 0.0% |
| 2021 Q4 | -18.85 Million AUD | 0.0% |
| 2021 FY | -29.76 Million AUD | -76.36% |
| 2021 Q2 | -11.17 Million AUD | 0.0% |
| 2020 Q2 | -8.62 Million AUD | 0.0% |
| 2020 FY | -16.87 Million AUD | -42.12% |
| 2020 Q4 | -8.25 Million AUD | 0.0% |
| 2019 FY | -11.87 Million AUD | -6185.31% |
| 2019 Q2 | -6.17 Million AUD | 0.0% |
| 2019 Q4 | -5.7 Million AUD | 0.0% |
| 2018 FY | 195.14 Thousand AUD | 5244.79% |
| 2018 Q2 | 48.78 Thousand AUD | 0.0% |
| 2018 Q1 | 48.78 Thousand AUD | 0.0% |
| 2018 Q4 | -440.75 Thousand AUD | 0.0% |
| 2017 Q4 | 48.78 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | -3793.00 AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | -20358.845% |
| Acrux Limited | -1.28 Million AUD | 24126.636% |
| Actinogen Medical Limited | 9.93 Million AUD | -3006.297% |
| AnteoTech Limited | 460.39 Thousand AUD | -66907.822% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -11774.884% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 1187605.293% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 41293.468% |
| Alterity Therapeutics Limited | 3.8 Million AUD | -8007.846% |
| Amplia Therapeutics Limited | 4.01 Million AUD | -7591.874% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 704522.879% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 102439.699% |
| Biome Australia Limited | 7.66 Million AUD | -3922.368% |
| Biotron Limited | -40.49 Thousand AUD | 761870.952% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 4808.848% |
| BTC Health Limited | 16.36 Thousand AUD | -1885609.046% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -4038.891% |
| CSL Limited | 15.28 Billion AUD | 97.982% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | -2581.072% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | -295.025% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -13222.52% |
| Dimerix Limited | 583.47 Thousand AUD | -52772.945% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | -505.554% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -24549.102% |
| Immuron Limited | 3.33 Million AUD | -9145.453% |
| Immutep Limited | 1.44 Million AUD | -21265.825% |
| Imugene Limited | -5.83 Million AUD | 5382.705% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -25348.585% |
| Memphasys Limited | 1606.00 AUD | -19209239.975% |
| Nanollose Limited | -348.95 Thousand AUD | 88508.148% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | -50.361% |
| Noxopharm Limited | -534.81 Thousand AUD | 57784.303% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 337862.353% |
| Nyrada Inc. | -5164.07 AUD | 5974108.873% |
| Orthocell Limited | 3.68 Million AUD | -8264.065% |
| PharmAust Limited | -1641.00 AUD | 18799734.369% |
| Patrys Limited | 1.39 Million AUD | -22028.116% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -542922.601% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 27566.615% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -8210.123% |
| PYC Therapeutics Limited | 22.05 Million AUD | -1298.511% |
| Race Oncology Limited | 1.38 Million AUD | -22095.746% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 1547.812% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 84213.663% |
| Starpharma Holdings Limited | 7.65 Million AUD | -3929.019% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -204869.736% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -2999724.971% |